-
1 Comment
Sequent Scientific Limited is currently in a long term uptrend where the price is trading 26.3% above its 200 day moving average.
From a valuation standpoint, the stock is 6.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Sequent Scientific Limited's total revenue rose by 13.2% to $4B since the same quarter in the previous year.
Its net income has increased by 83.3% to $372M since the same quarter in the previous year.
Finally, its free cash flow grew by 203.1% to $843M since the same quarter in the previous year.
Based on the above factors, Sequent Scientific Limited gets an overall score of 5/5.
| ISIN | INE807F01027 |
|---|---|
| Exchange | NSE |
| CurrencyCode | INR |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 44B |
|---|---|
| PE Ratio | 205.62 |
| Target Price | 133.5 |
| Beta | 0.91 |
| Dividend Yield | None |
Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SEQUENT.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
